Advanced Search
Click Traffic
  • Number of total visits : 3978844
  • Number of visits today : 502
  • Number of users online :0
  • Number of downloads :1469028
Yue Li

EXPERT INTRODUCTION

Yue Li, chief physician, is the director of the Fifth Section Cardiology Department and the associate director of the Central Laboratory of the First Affiliated Hospital of Harbin Medical University (HMU). As a director of Master, Prof. Yue Li was granted doctoral degree by HMU in 2004 and then started studying as a Postdoctoral Research Fellow in Cardiovascular Pharmacology, School of Pharmacy, HMU, and went to the Vanderbilt University as a Visiting Scholar in 2009. Prof. Yue Li has published over 5 books and 100 papers in domestic and international core journals. At present, Prof. Yue Li is mainly engaged in interventional treatment of coronary heart disease.

SOCIETY MEMBERSHIPS

1  Youth Committee of Chinese Society for Medicine Cardiology Committee

2  Evaluation Experts of Chinese Medical Journal

3  Editor of Chinese Journal of Interventional Cardiology

4  Editor of Chinese Journal of Practical Internal Medicine

5  Editor of Chinese Journal of Medicine

6  Editor of Chinese Journal of Cardiovascular Review

7  Standing Director of Heilongjiang Medical Doctor Association

8  Commissioner& Secretary of Cardiovascular Committee of Heilongjiang Medical Doctor Association

9  Member of Experts Group of Harbin Clinical Drug Guide Committee

10 The backup academic leader of cardiovascular department of the First Affiliated Hospital of HMU (Provincial key discipline).

11 The chief writer of Journal of CCHEART REVIEW.

PROJECT IN PROGRESS (selected):

1      The relationship between regulation of neurturin expression and atrial vagal nerve remodeling in chronic atrial fibrillation. National Natural Science Foundation.( 2010-2012).

2   Mechanism of vagus nerve remodeling during chronic atrial fibrillation. The Program for New Century Excellent Talents in University (NCET), Ministry of Education.( 2009-2012).

3   Mechanism and prevention of atrial autonomic remodeling during atrial fibrillation. Heilongjiang Key Technologies R&D Program. ( 2008-2009).

4   Mechanism and prevention of atrial structural and autonomic remodeling during atrial fibrillation. Program for New Century Excellent Talents In Heilongjiang Provincial University. (2007-2009)

5   Mechanism of vagus nerve remodeling during chronic atrial fibrillation. The Special Fund for Scientific and Technological Innovative Talents in Harbin, 2009-2011

6   Mechanism and prevention of atrial autonomic remodeling during atrial fibrillation, Foundation of the First Affiliated Hospital of Harbin Medical University, (2008-2009)

PUBLICATIONS:

A. BOOK CHAPTERS (selected):

1 The Topol Solution: Textbook of Cardiovascular Medicine, Third Edition(Chinese translated edition)  People’s Medical Publishing House (PMPH)  Reviser

2 Strategies and Techniques of Intervention therapy for coronary heart disease

People’s Medical Publishing House (PMPH) associate editor

B. ARTICLES (selected):

1 Zhao J, Hang P, Li Y. TRPC6, a potential novel target for enhancing cardiac repair of bone marrowmesenchymal stem cells. Int J Cardiol, 2012, 155(3): 497-498. (IF: 6.802).

2  Li Y, Shi J, Yang B, Liu L, Han C, Li W, Dong D, Pan Z, Liu G, Geng J, Sheng L, Tan X, Sun D, Gong Zh, Gong Y. Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol. Br J Pharmacol, 2012, 165(6): 1748-1756. (IF: 5.204).

3  Yu J, Li W, Li Y, Zhao J, Wang L, Dong D, Pan Z, Yang B. Activation of β(3)-adrenoceptor promotes rapid pacing-induced atrial electrical remodeling in rabbits. Cell Physiol Biochem, 2011, 28(1): 87-96. (IF: 3.585).

4  Zhao JY, Li JQ, Li WM, Li Y, Shan HB, Gong YT, Yang BF. Effects of spironolactone on atrial structural remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol, 2010, 159(8): 1584-1594. (IF: 4.925).

5  Li Y, Sheng L, Li WM, Liu W, Gong YT, Xue HJ, Shan HB. Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs. Biochem Biophys Res Commun, 2009, 381(2): 198-203. (IF: 2.595)

6  Li Y, Gong ZH, Xue HJ, Sheng L, Li WM, Gong YT. Anti-apoptotic effects of a calpain inhibitor on cardiomyocytes in a canine rapid atrial fibrillation model. Cardiovas Drugs Ther, 2009, 23(5): 361368. (IF: 3.098)

7  Gong YT, Li WM, Li Y, Yang SS, Sheng L, Yang N, Shan HB, Xue HJ, Liu W, Yang BF, Dong DL, Li BX. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Chin Med J (Engl), 2009, 122(1): 74-82. (IF: 0.983)

8  Xue HJ, Li WM, Li Y, Gong YT, Yang BF, Jin CL, Sheng L, Chu S, Zhang L, Shan HB, Liu J. Calpain I inhibition prevents atrial structural remodeling in a canine model with atrial fibrillation. Chin Med J (Engl), 2008, 121(1): 32-37. (IF: 0.858)

9  Li W, Li Y, Sheng L, Gong Y. Myocardial bridge: is the risk of perforation increased? Can J Cardiol, 2008, 24(11): e80-81. (F: 2.224)

10 Li Y, Li WM, Gong YT, Li BX, Liu W, Han W, Dong D, Sheng L, Xue JY, Zhang L, Chu S, Yang BF. The effects of cilizapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Basic Res Cardiol, 2007, 102(3): 245-256. (IF: 6.128)

11  Li Y, Li WM, Yang B, Han W, Dong D, Xue J, Li B, Yang S, Sheng L. Effects of cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs. J Electrocardiol, 2007, 40(1): 100.e1-6. (IF: 1.109)

12  Li WM, Li Y, Zhao JY, Duan YN, Sheng L, Yang BF, Wang FL, Gong YT, Yang SS, Zhou LJ, Liu PD, Zhang L, Chu S. Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction. Chin Med J (Engl), 2007, 120(7): 598-600. (IF: 0.983)

13  Li Y, Li WM, Xue JY, Han W, Yang SS, Gu HY. Effects of losartan on acute atrial electrical remodeling. Chin Med J (Engl), 2004, 117(5): 643-646. (IF: 0.983)